| HSWSX | VTIAX | HSWSX / VTIAX | |
| Total Expense Ratio | 1.11 | 0.09 | 1,233% |
| Annual Report Gross Expense Ratio | 1.11 | 0.09 | 1,233% |
| Fund Existence | 10 years | 16 years | - |
| Gain YTD | 6.981 | 13.589 | 51% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.56B | 652B | 1% |
| Annual Yield % from dividends | 2.25 | 2.63 | 86% |
| Returns for 1 year | 14.20 | 25.55 | 56% |
| Returns for 3 years | 47.86 | 54.95 | 87% |
| Returns for 5 years | 34.80 | 32.79 | 106% |
| Returns for 10 years | N/A | 113.72 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ESAGX | 17.11 | 0.33 | +1.96% |
| Ashmore Emerging Markets Equity ESG A | |||
| VREQX | 11.86 | 0.12 | +1.02% |
| NYLI CBRE Real Estate Class R6 | |||
| AFVLX | 26.11 | 0.23 | +0.89% |
| Applied Finance Select Investor | |||
| MKVIX | 18.75 | 0.08 | +0.43% |
| MFS International Large Cap Value I | |||
| LGOAX | 51.59 | 0.08 | +0.16% |
| Patient Opportunity A | |||